Introduction
Mild zinc de®ciency is thought to be widespread in poor populations with limited access to a varied diet (Sandstead, 1991) . Among such populations, infants of low birth weight (LBW) may be particularly vulnerable as intrauterine growth retardation is associated with reduced liver size at birth (Usher & McLean, 1974) and hepatic zinc-metallotheonein is thought to act as a zinc reserve in infants (Aggett, 1994) . Consequently term LBW infants can be expected to have a smaller zinc reserve than other infants. In northeast Brazil, the prevalence of LBW is about 9%. We surmised that term LBW infants in the northeast of Brazil are likely to be de®cient in zinc because of reduced zinc stores at birth, limited access to dietary sources because of poverty, and poor bioavailability since breastfeeding durations are short.
Animal studies show an adverse effect of zinc de®ciency in utero and early life on brain weight, composition and function (Sandstead, 1985; Frederickson, 1989; Wallwork & Sandstead, 1993 ). When behaviour is tested concurrently with zinc deprivation in immature animals, the prominent characteristics are reduced activity and responsiveness, but learning, attention and memory are also affected (Golub et al, 1995 (Golub et al, , 1996 . We have previously reported that term LBW infants in northeast Brazil performed less well in the Bayley tests of motor and mental development and were more inhibited than infants of appropriate birth weight (ABW), and less active, cooperative, vocal and happy during their developmental assessments (GranthamMcGregor et al, 1998) . At 6-months of age, the mean difference in their mental development index (MDI) was 4 points and this widened to 7 points at 12-months. For the psychomotor development index (PDI), the mean difference was 7 points at 6-months and 10 points at 12-months. We hypothesised that zinc de®ciency may be impairing their mental and motor development, and that zinc supplementation might be bene®cial. In this paper we therefore compare the development and behaviour of term LBW infants who received 5 mg zinc daily during their ®rst eight weeks of life with infants who received a placebo or 1 mg zinc. Testing was performed at 6 and 12-months of age.
Subjects and methods
Details of the location, subject eligibility, and study procedures have been given in previous publications (Lira et al, 1996; Grantham-McGregor et al, 1998) . Brie¯y, the study took place in the interior of the state of Pernambuco where most of the population are poor and where the economy is heavily dependent on sugar-cane production. Five maternity centres serve this area, and over 90% of deliveries occur there. During a 13-month period beginning in January 1993, all singleton LBW term infants weighing 1500±2499 g born to families of low income (equivalent tò US$280 per month) were recruited for the study. Gestational age was assessed by one of two paediatricians by the method of Capurro et al (1978) . Infants with congenital anomalies, abnormal neurological signs, or signs of asphyxia were excluded. All were well enough to go home within two days of birth and no infant had respiratory infections in the ®rst week. The intention was to give 5 mg zinc or a placebo daily except Sundays, for eight weeks from birth, in a randomized, double-blind trial. A mistake in the manufacture of the zinc solution resulted in the initial cohort being given 1 mg instead of 5 mg. When this was discovered, the design was modi®ed and the enrolment period was extended to include a second cohort of infants who would all receive 5 mg zinc. Inclusion and exclusion criteria remained the same and all ®eld workers and participating families were unaware of the change and remained blind to treatment allocation. Thus, during a 13-month period from January 1993, 66 LBW term infants were randomly allocated to receive the placebo and 68 received 1 mg zinc. During February±August 1994, 71 LBW term infants received 5 mg zinc.
Zinc supplement placebo
The supplement was zinc sulphate (ZnSO 4 Á 7H 2 O) masked in sorbitol and¯avour. The placebo was similar in appearance and taste (sorbitol and¯avour). A ®eld worker, using a disposable syringe, administered 0.5 ml of the supplement placebo at home in the presence of the mother or caretaker daily except Sundays, from birth for eight weeks. If an infant was hospitalised, the ®eld worker went to the hospital to give the dose. Bottles were kept by the ®eld worker to prevent tampering, and a photograph of the infant's mother was af®xed to the bottle to prevent misallocation.
Other zinc sources At 4, 8, 17 and 26 weeks, any zinc-containing ointments, creams or tonics given by parents were recorded. Consumption of speci®c zinc-rich foods was also ascertained on these occasions.
Data collection
Developmental tests. Infants were scheduled to have their development assessed at 6 and 12-months using the two subscales of the Bayley Scales of Infant Development. They were tested in the presence of their mothers and any infant who was sick at the scheduled test time was treated and the test postponed. Two paediatricians shared the testing at 6-months, and one of them undertook all the 12-month tests. Both were blind to treatment allocation.
Behaviour. At 12-months the infants' behaviour was rated on 5 scales, each with a 9-point range. These were: responsiveness to the tester in the ®rst 10 min of the test (avoiding 1, friendly and inviting 9), emotional tone (unhappy throughout 1, happy throughout 9), activity level (very still 1, very active 9), cooperation with the test procedure (resists all suggestions 1, always complies 9) and amount of vocalisation (very quiet 1, constant vocalisation 9). The scales were adapted from the rating scales of Bayley (1993) and Wolke et al (1990) . We ®rst selected behaviours that we hypothesised were likely to be affected by nutritional factors (GranthamMcGregor et al, 1990) and retained those that proved reliable when tested during the pilot phase.
Home Environment. The Caldwell Home Inventory (Caldwell 1967 ) was used to provide an index of stimulation. It was modi®ed for local cultural and socioeconomic conditions and rescaled. The index comprised 43 questions or observation items, and the total score was used for the analysis. The infants' socioeconomic environment was assessed on the basis of four indicators: (i) family income for the month preceding birth (expressed as minimum salaries), (ii) household resources (scaled 0±5), (iii) housing quality (scaled 0±16) and (iv) water and sanitation (scaled 0±6). Reported parental literacy was also recorded. The mothers were interviewed at home by one of two female interviewers.
Morbidity and feeding. Infant morbidity and feeding status were recorded daily during home interviews (except Sundays) from birth to eight weeks of age, and then twice weekly until 6-months. The morbidity questionnaire focused on maternally perceived symptoms of diarrhoea, cough, vomiting, fever and cansac Ëo (a local term for rapid breathing). The feeding questionnaire focused on the number of breastfeeds and other feeds (excluding water, juice and tea).
Anthropometry. Birth weight and length were measured for 67% of infants within 12 h of birth, and only two were measured after 24 h. Procedures and equipment have been described previously (Lira et al, 1996) . Weight and length were remeasured at 4, 8, 17, 26 and 52 weeks.
Quality control
The zinc content of the supplement and placebo solutions was veri®ed by the Pernambuco State Institute for Technology, Brazil and the Middlesex Hospital, UK. A 10% sample of individual bottles was also checked against the randomization code. No errors were detected. Gestational age was assessed independently by the two paediatricians for 20% of the infants with good interobserver reliability (k 0.86). Approximately 8% of the Bayley tests were witnessed by a second observer and scored independently. Interobserver correlations were high for both MDI and PDI and were above r 0.94 at 6 and 12-months. For the behaviour ratings, interobserver agreement was assessed between the tester and trainer in 10 consecutive tests before the study began. During the study, 18 further tests were witnessed independently by a second observer. Interobserver correlations were high, ranging from 0.84 for cooperation to 0.96 for activity level. Approximately 10% of interviews to assess home stimulation were scored independently by a second observer. Interobserver agreement was high, with complete agreement for at least 41 of the 43 variables.
Statistical methods
Questionnaires were pre-coded and checked daily for completeness, accuracy and consistency. Double data entry was performed by two data clerks using dBase-III (Ashton Tate, Torrance CA) and veri®ed. Differences among the groups were assessed using a standard chi-squared test for proportions (Kirkwood, 1988) , analysis of variance (ANOVA) for normally-distributed continuous variables (Kirkwood, 1988) , and the non-parametric Kruskal-Wallis test for non-normally distributed continuous variables (Altman, 1991) . The Kruskal-Wallis test is the multi-sample generalisation of the more familiar two-sample Wilcoxon (Mann-Whitney) rank sum test. In addition, because the ®ve behaviour ratings were correlated one with another, we tested the hypothesis that the population means for all ®ve behaviour scores were simultaneously no different across the three treatment groups using Multivariate Analysis of Variance. The test statistic selected to test this hypothesis was Hotelling's Trace (Olsen, 1976) , but Pillai's Trace and Wilk's Lambda both gave almost identical P-values. Three of the ®ve behaviour scores were ®rst transformed (raised to the power three) to remove the pronounced skew in the distributions, which would otherwise have affected the validity of the test result. Analyses were conducted using the Statistical Package for the Social Sciences (SPSS) for Windows, version 6.1 (SPSS Inc., Chicago IL).
Ethics
Ethical permission was obtained from the ethics committees of the London School of Hygiene and Tropical Medicine, the Universidade Federal de Pernambuco, and the Fundac Ëa Äo Nacional de Sau Âde. Mothers knew they could withdraw their child from the study at any time. Sick infants were referred to a local health service according to a standard protocol.
Results
Losses from the study By the 6-months' test, 29 infants (14%) had moved out of the area and 13 (6%) died. Thus Bayley tests were carried out at 6-months on 53 (80%) placebo infants, 56 (82%) 1 mg and 54 (76%) 5 mg infants. By the 12-months' test, there were 25 further losses (9 placebo infants and 8 in each of the zinc groups).
Comparability of the groups
Since infants were randomly allocated to placebo and 1 mg zinc treatments, between-group differences in characteristics that might in¯uence development could only have arisen by chance. The 5 mg zinc group, however was not randomly allocated. Formal statistical tests were therefore used to compare the three groups with respect to characteristics of the infants, their mothers and their family environments. Table 1 shows selected variables from among those examined. At birth, the groups were comparable except the 5 mg zinc group had smaller head size and were longer, and their mothers were taller (data not shown). During the trial, infants who received 5 mg zinc had signi®cantly less diarrhoea than other infants. Very few infants in any group regularly received zinc-containing ointments, tonics, or zinc-forti®ed formulas. Few consumed zinc-rich foods. Examination of the characteristics of infants lost to follow-up showed that these were comparable across the three treatment groups. Table 2 shows for each treatment group mental and psychomotor scores at 6 and 12-months. Zinc supplementation for eight weeks from birth did not improve the scores. Adjusting for the smaller head size length ratio in the 5 mg zinc group did not affect the outcome.
Supplementation and Bayley scores

Supplementation and behaviour
The rating for responsiveness to tester was signi®cantly higher in infants given 5 mg zinc (Kruskal-Wallis test, P 0.023). The other behaviour ratings did not differ signi®cantly when analyzed individually (Table 2 ), but a 
Discussion
Since zinc de®ciency is believed to be common in developing countries, any associated impairment in cognitive or psychomotor development would be of profound public health signi®cance. Animal experiments, including studies in non-human primates indicate that long-term impairment does occur in animals exposed to severe zinc de®ciency during the period of rapid brain growth (Golub et al, 1995) . Characteristic of rhesus monkeys marginally deprived of zinc from conception onwards is reduced responsiveness associated with hypoactivity. Human studies are very limited as yet and, because many factors affect child development, a causal association between zinc de®ciency and development can only be inferred from supplementation trials. We have located six randomised trials. Three focused on speci®c cognitive functions. The ®rst was in southern Ontario, Canada, among 60 boys aged 5±7 y who were of short stature (Gibson et al, 1989) . Supplementation was for 12-months and attention span and working memory were assessed on four subtests of the Detroit Tests of Learning Aptitude. No treatment effect was found. Similarly in Guatemala with the same Test but utilising three subtests, no bene®t of zinc supplementation was detected in 162 children aged 5±7 y from poor families. The mean duration of supplementation was 90 d (Cavan et al, 1993) . In contrast, in China, neurocognitive function was better in children aged 6±9 y supplemented with zinc for 10 weeks, or zinc with other micronutrients, compared with children with micronutrients alone (Penland et al, 1997) . In one study of very low birth weight infants in Newfoundland, Canada, psychomotor development in the ®rst year of life was examined and was found to improve with 3 months' zinc supplementation (Friel et al, 1993) . Mental development, however, did not improve. In two other trials, investigators observed children's behaviour and found changes in activity patterns. One was in India with 93 poor children aged 12±23 months and those randomised to receive zinc for 6-months were markedly more active than placebo children (Sazawal et al, 1996) . The other trial was in Guatemala in 85 infants who were supplemented for 7 months from the age of 6±9 months (Bentley et al, 1997) .
At the end of the trial, infants who had received zinc were more frequently observed to be sitting up and playing, and less likely to be lying down, than placebo infants. These effects were not apparent after 3 months' supplementation. Our study is thus the ®rst to focus on term LBW infants. Although we have previously shown that these infants have substantial de®cits in MDI and PDI compared to ABW infants, zinc supplementation was not associated with any improvement in their scores. The study had 85% power to detect a difference of 4 DQ points at 6-months. Diarrhoea detrimentally affects the development of LBW infants in this population and since 5 mg zinc was associated with a signi®cant reduction in diarrhoea (Lira et al, 1997) , the lack of a signi®cant impact on development may seem surprising. The prevalence of diarrhoea was, however, quite low in the ®rst 6-months of life, and the difference in PDI score attributable to diarrhoea was modest (`1 point at 6-months).
Infants receiving 5 mg zinc were more responsive to the tester than other infants in that they were more friendly and less inhibited or fearful (P 0.023). That responsiveness should be associated with zinc supplementation is interesting, given the suggestion of Golub and her colleagues that changes in activity and responsiveness provide a sensitive index of dietary zinc adequacy (Golub et al, 1995) . Although this could be a chance ®nding we think this unlikely as the 5 mg zinc group had the highest scores on all ®ve behaviour ratings. Undernourished children in general have been described as shy and inhibited, and it is possible that zinc de®ciency contributes to this behaviour. Since infants receiving 5 mg zinc were not randomly allocated, unlike the 1 mg and placebo groups, we cannot be entirely certain that zinc was the causal factor in their improved behaviour. Nevertheless, the 5 mg zinc group had comparable socioeconomic and demographic characteristics to the other groups and the macroenvironment was similar in 1993 and 1994. Infants were tested by the same Zinc supplementation, mental development and behaviour in Brazilian infants A Ashworth et al testers and under the same conditions throughout. During the study, losses tended to be among infants with the lowest Bayley scores. Since losses were similar in all three groups, this bias should not affect interpretation of the results. The supplementation period was just eight weeks because of perceived health service implications as we considered that if, in the future, zinc supplements were to be provided through existing health service channels, compliance may be of limited duration. Although eight weeks' supplementation appears suf®cient for a bene®cial effect on diarrhoea prevalence, it may be too short to bene®t mental and motor function. If the duration of zinc supplementation were to be restricted for logistical or other reasons, it may be preferable to start supplementation when breastfeeding ends, ie when intakes of bioavailable zinc decrease.
The mechanisms whereby zinc affects brain function and behaviour are not yet clearly de®ned, but zinc appears to induce the release of the neurotransmitter g aminobutyric acid (GABA) and thus in¯uence neuronal excitability and modulate synaptic transmission (Frederickson, 1989; Smart, 1990; Xie & Smart, 1991) . Zinc is concentrated in speci®c neuronal structures, notably in the nerve terminals of the hippocampus (mossy ®bre system), cortex and pineal body. GABA may also have a trophic role in neuronal cell growth and differentiation (Ben-Ari & Cherubini, 1991) .
Conclusions
This study perhaps raises more questions than it answers. The data indicate that supplementation with 5 mg zinc may reverse some of the poor responsiveness exhibited by LBW infants. No amelioration of the MDI and PDI de®cits was evident. Further supplementation studies are warranted in which zinc is given to LBW infants later and for longer.
